Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors

Published:2018-05-09 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Smolarczyk Ryszard,Cichoń Tomasz,Pilny Ewelina,Jarosz-Biej Magdalena,Poczkaj Aleksandra,Kułach Natalia,Szala Stanisław

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-25688-y.pdf

Reference30 articles.

1. Mita, M. M., Sargsyan, L., Mita, A. C. & Spear, M. Vascular-disrupting agents in oncology. Expert Opin. Investig. Drugs 22, 317–328 (2013).

2. Kim, S., Peshkin, L. & Mitchison, T. J. Vascular disrupting agent drug classes differ in effects on the cytoskeleton. PLoS One 7, e40177, https://doi.org/10.1371/journal.pone.0040177 (2012).

3. Su, M. et al. The anti-angiogenic effect and novel mechanisms of action of combretastatin A-4. Sci. Rep. 6, 28139, https://doi.org/10.1038/srep28139 (2016).

4. Surpris, G. & Poltorak, A. The expanding regulatory network of STING-mediated signaling. Curr. Opin. Microbiol. 32, 144–150 (2016).

5. Poltorak, A., Kurmyshkina, O. & Volkova, T. Stimulator of interferon genes (STING): a “new chapter” in virus-associated cancer research. Lessons from wild-derived mouse models of innate immunity. Cytokine Growth Factor Rev. 29, 83–91 (2016).

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyaluronidase improves the efficacy of nab-paclitaxel after prolonged angiogenesis inhibition in preclinical models for esophagogastric cancer;Biomedicine & Pharmacotherapy;2024-09

2. Targeting the tumour vasculature: from vessel destruction to promotion;Nature Reviews Cancer;2024-08-29

3. Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy;Journal of Translational Medicine;2024-03-03

4. Research Progress on Tumor Microenvironment and Radiotherapy Sensitivity;Advances in Clinical Medicine;2024

5. Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context;Frontiers in Oncology;2023-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3